Advertisement
Screener

Lantheus Holdings, Inc. (LNTH) Increase (Decrease) in Other Noncurrent Liabilities

Lantheus Holdings, Inc. Increase (Decrease) in Other Noncurrent Liabilities

Lantheus Holdings, Inc. (LNTH) reported Increase (Decrease) in Other Noncurrent Liabilities of $687.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities · last filed 2026-08-06

  • Lantheus Holdings, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2026-06-30 was $603.00K.
  • Lantheus Holdings, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2026-03-31 was $84.00K, a 86.85% decline year-over-year.
  • Lantheus Holdings, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2025-12-31 was $3.00M, a 14.64% increase year-over-year.
  • Lantheus Holdings, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2025-09-30 was -$2.75M, a 366.83% decline year-over-year.
  • Lantheus Holdings, Inc. increase (decrease) in other noncurrent liabilities for fiscal 2025 was $246.00K, a 95.30% decline from fiscal 2024.
  • Lantheus Holdings, Inc. increase (decrease) in other noncurrent liabilities for fiscal 2024 was $5.24M.
  • Lantheus Holdings, Inc. increase (decrease) in other noncurrent liabilities for fiscal 2023 was -$3.10M.
  • Lantheus Holdings, Inc. increase (decrease) in other noncurrent liabilities for fiscal 2022 was -$12.48M.
Period endIncrease (Decrease) in Other Noncurrent Liabilities 3 monthIncrease (Decrease) in Other Noncurrent Liabilities 6 monthIncrease (Decrease) in Other Noncurrent Liabilities 9 monthIncrease (Decrease) in Other Noncurrent Liabilities 12 month
2026-06-30$603.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
$687.00K
10-Q · filed 2026-08-06
$3.69M
derived: sum of 3 quarters · filed 2026-08-06
$936.00K
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31$84.00K
10-Q · filed 2026-05-07
$3.08M
derived: sum of 2 quarters · filed 2026-05-07
$333.00K
derived: sum of 3 quarters · filed 2026-05-07
-$309.00K
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31$3.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$249.00K
derived: sum of 2 quarters · filed 2026-02-26
-$393.00K
derived: sum of 3 quarters · filed 2026-08-06
$246.00K
10-K · filed 2026-02-26
2025-09-30-$2.75M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
-$3.39M
derived: sum of 2 quarters · filed 2026-08-06
-$2.75M
10-Q · filed 2025-11-06
-$137.00K
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30-$642.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
-$3.00K
10-Q · filed 2026-08-06
$2.61M
derived: sum of 3 quarters · filed 2026-08-06
$3.65M
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31$639.00K
10-Q · filed 2026-05-07
$3.26M
derived: sum of 2 quarters · filed 2026-05-07
$4.29M
derived: sum of 3 quarters · filed 2026-05-07
$5.44M
derived: sum of 4 quarters · filed 2026-05-07
2024-12-31$2.62M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$3.65M
derived: sum of 2 quarters · filed 2026-02-26
$4.80M
derived: sum of 3 quarters · filed 2026-02-26
$5.24M
10-K · filed 2026-02-26
2024-09-30$1.03M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
$2.18M
derived: sum of 2 quarters · filed 2025-11-06
$2.62M
10-Q · filed 2025-11-06
$2.26M
derived: sum of 4 quarters · filed 2026-02-26
2024-06-30$1.15M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06
$1.59M
10-Q · filed 2025-08-06
$1.23M
derived: sum of 3 quarters · filed 2026-02-26
-$2.90M
derived: sum of 4 quarters · filed 2026-02-26
2024-03-31$439.00K
10-Q · filed 2025-05-07
$80.00K
derived: sum of 2 quarters · filed 2026-02-26
-$4.05M
derived: sum of 3 quarters · filed 2026-02-26
-$2.79M
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31-$359.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$4.49M
derived: sum of 2 quarters · filed 2026-02-26
-$3.23M
derived: sum of 3 quarters · filed 2026-02-26
-$3.10M
10-K · filed 2026-02-26
2023-09-30-$4.13M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06
-$2.87M
derived: sum of 2 quarters · filed 2024-11-06
-$2.74M
10-Q · filed 2024-11-06
-$14.68M
derived: sum of 4 quarters · filed 2025-02-26
2023-06-30$1.26M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31
$1.39M
10-Q · filed 2024-07-31
-$10.55M
derived: sum of 3 quarters · filed 2025-02-26
-$12.24M
derived: sum of 4 quarters · filed 2025-02-26
2023-03-31$123.00K
10-Q · filed 2024-05-02
-$11.82M
derived: sum of 2 quarters · filed 2025-02-26
-$13.51M
derived: sum of 3 quarters · filed 2025-02-26
-$13.13M
derived: sum of 4 quarters · filed 2025-02-26
2022-12-31-$11.94M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26
-$13.63M
derived: sum of 2 quarters · filed 2025-02-26
-$13.26M
derived: sum of 3 quarters · filed 2025-02-26
-$12.48M
10-K · filed 2025-02-26
2022-09-30-$1.69M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02
-$1.32M
derived: sum of 2 quarters · filed 2023-11-02
-$538.00K
10-Q · filed 2023-11-02
-$4.83M
derived: sum of 4 quarters · filed 2024-02-22
2022-06-30$375.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03
$1.15M
10-Q · filed 2023-08-03
-$3.14M
derived: sum of 3 quarters · filed 2024-02-22
-$7.91M
derived: sum of 4 quarters · filed 2024-02-22
2022-03-31$779.00K
10-Q · filed 2023-05-04
-$3.52M
derived: sum of 2 quarters · filed 2024-02-22
-$8.28M
derived: sum of 3 quarters · filed 2024-02-22
-$7.86M
derived: sum of 4 quarters · filed 2024-02-22
2021-12-31-$4.29M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22
-$9.06M
derived: sum of 2 quarters · filed 2024-02-22
-$8.64M
derived: sum of 3 quarters · filed 2024-02-22
-$7.91M
10-K · filed 2024-02-22
2021-09-30-$4.76M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03
-$4.34M
derived: sum of 2 quarters · filed 2022-11-03
-$3.62M
10-Q · filed 2022-11-03
-$2.90M
derived: sum of 4 quarters · filed 2023-02-23
2021-06-30$419.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04
$1.15M
10-Q · filed 2022-08-04
$1.86M
derived: sum of 3 quarters · filed 2023-02-23
$2.57M
derived: sum of 4 quarters · filed 2023-02-23
2021-03-31$728.00K
10-Q · filed 2022-04-29
$1.44M
derived: sum of 2 quarters · filed 2023-02-23
$2.15M
derived: sum of 3 quarters · filed 2023-02-23
$2.85M
derived: sum of 4 quarters · filed 2023-02-23
2020-12-31$714.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23
$1.42M
derived: sum of 2 quarters · filed 2023-02-23
$2.12M
derived: sum of 3 quarters · filed 2023-02-23
$2.83M
10-K · filed 2023-02-23
2020-09-30$705.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04
$1.41M
derived: sum of 2 quarters · filed 2021-11-04
$2.11M
10-Q · filed 2021-11-04
-$12.15M
derived: sum of 4 quarters · filed 2022-02-24
2020-06-30$704.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-28
$1.41M
10-Q · filed 2021-07-28
-$12.86M
derived: sum of 3 quarters · filed 2022-02-24
-$13.78M
derived: sum of 4 quarters · filed 2022-02-24
2020-03-31$705.00K
10-Q · filed 2021-05-04
-$13.56M
derived: sum of 2 quarters · filed 2022-02-24
-$14.49M
derived: sum of 3 quarters · filed 2022-02-24
-$13.47M
derived: sum of 4 quarters · filed 2022-02-24
2019-12-31-$14.27M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24
-$15.19M
derived: sum of 2 quarters · filed 2022-02-24
-$14.17M
derived: sum of 3 quarters · filed 2022-02-24
-$13.16M
10-K · filed 2022-02-24
2019-09-30-$923.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05
$95.00K
derived: sum of 2 quarters · filed 2020-11-05
$1.11M
10-Q · filed 2020-11-05
$1.94M
derived: sum of 4 quarters · filed 2021-02-25
2019-06-30$1.02M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31
$2.04M
10-Q · filed 2020-07-31
$2.86M
derived: sum of 3 quarters · filed 2021-02-25
$3.74M
derived: sum of 4 quarters · filed 2021-02-25
2019-03-31$1.02M
10-Q · filed 2020-04-30
$1.84M
derived: sum of 2 quarters · filed 2021-02-25
$2.72M
derived: sum of 3 quarters · filed 2021-02-25
$3.38M
derived: sum of 4 quarters · filed 2021-02-25
2018-12-31$822.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25
$1.70M
derived: sum of 2 quarters · filed 2021-02-25
$2.37M
derived: sum of 3 quarters · filed 2021-02-25
$3.22M
10-K · filed 2021-02-25
2018-09-30$880.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31
$1.54M
derived: sum of 2 quarters · filed 2019-10-31
$2.40M
10-Q · filed 2019-10-31
$3.07M
derived: sum of 4 quarters · filed 2020-02-25
2018-06-30$663.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-25
$1.52M
10-Q · filed 2019-07-25
$2.19M
derived: sum of 3 quarters · filed 2020-02-25
$2.95M
derived: sum of 4 quarters · filed 2020-02-25
2018-03-31$854.00K
10-Q · filed 2019-04-30
$1.53M
derived: sum of 2 quarters · filed 2020-02-25
$2.29M
derived: sum of 3 quarters · filed 2020-02-25
$2.88M
derived: sum of 4 quarters · filed 2020-02-25
2017-12-31$673.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25
$1.44M
derived: sum of 2 quarters · filed 2020-02-25
$2.02M
derived: sum of 3 quarters · filed 2020-02-25
$2.79M
10-K · filed 2020-02-25
2017-09-30$763.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30
$1.35M
derived: sum of 2 quarters · filed 2018-10-30
$2.12M
10-Q · filed 2018-10-30
2017-06-30$588.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01
$1.36M
10-Q · filed 2018-08-01
2017-03-31$769.00K
10-Q · filed 2018-05-02
2016-12-31$565.00K
10-K · filed 2019-02-20
2015-12-31$638.00K
10-K · filed 2018-02-26
2014-12-31-$2.56M
10-K · filed 2017-02-23
2013-12-31$187.00K
10-K · filed 2016-03-02

Similar stocks

Stock NameCountryMarket CapPE Ratio
NEOGEN CORP (NEOG)United States$2.979B-247.49
Celldex Therapeutics, Inc. (CLDX)United States$2.471B-9.72
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
BIOMERICA INC (BMRA)United States$0.011B